Last reviewed · How we verify
Glyxambi film-coated tablets — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Glyxambi film-coated tablets (Glyxambi film-coated tablets) — Humanis Saglık Anonim Sirketi.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Glyxambi film-coated tablets TARGET | Glyxambi film-coated tablets | Humanis Saglık Anonim Sirketi | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Glyxambi film-coated tablets CI watch — RSS
- Glyxambi film-coated tablets CI watch — Atom
- Glyxambi film-coated tablets CI watch — JSON
- Glyxambi film-coated tablets alone — RSS
Cite this brief
Drug Landscape (2026). Glyxambi film-coated tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/glyxambi-film-coated-tablets. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab